Because of the paucity of primate experimental models, the precise molecular mechanism of ischemic neuronal death remains unknown in humans. This study focused on nonhuman primates to determine which cascade necrosis or apoptosis is predominantly involved in the development of delayed (day 5) neuronal death in the hippocampal CA1 sector undergoing 20 min ischemia. We investigated expression, activation, and/or translocation of -calpain, lysosome-associated membrane protein-1 (LAMP-1), caspase-3, and caspase-activated DNase (CAD), as well as morphology of the postischemic CA1 neurons and DNA electrophoresis pattern. Immunoblotting showed sustained (immediately after ischemia until day 5) and maximal (day 3) activation of -calpain. The immunoreactivity of activated -calpain became remarkable as coarse granules at lysosomes on day 2, while it translocated throughout the perikarya on day 3. The immunoreactivity of LAMP-1 also showed a dynamic and concomitant translocation that was maximal on days 2-3, indicating calpain-mediated disruption of the lysosomal membrane after ischemia. In contrast, immunoblotting demonstrated essentially no increase in the activated caspase-3 at any time points after ischemia, despite upregulation of pro-caspase-3. Although expression of CAD was slightly upregulated on day 1 or 2, or both, it was much less compared with lymph node or intestine tissues. Furthermore, light and electron microscopy showed eosinophilic coagulation necrosis and membrane disruption without apoptotic body formation, while DNA electrophoresis did not show a ladder pattern, but rather a smear pattern. Sustained calpain activation and the resultant lysosomal rupture, rather than CAD-mediated apoptosis, may cause ischemic neuronal necrosis in primates.
INTRODUCTION
From rodents (Kirino, 1982; Pulsineli et al., 1982) to monkeys (Tabuchi et al., 1992; Yamashima et al., 1996) and humans (Petito et al., 1987; Horn and Schlote, 1992) , transient brain ischemia is well known to cause delayed neuronal death in the hippocampal CA1 sector (CA1). Delayed neuronal death occurs a few days after the ischemic insult, but which cascade necrosis or apoptosis is mainly involved remains uncertain. Ultrastructural data have shown that the postischemic CA1 neurons display necrotic rather than apoptotic features (Colbourne et al., 1999; Tsukada et al., 2001; Zhao et al., 2002) , while a number of reports indicate that apoptosis contributes to ischemic neuronal death (MacManus et al., 1993; Nitatori et al., 1995; Vexler et al., 1997; MacManus and Linnik, 1997; Chen et al., 1998; Mukasa et al., 1999) . Accordingly, there is no consensus as to what is the final effector of CA1 neuronal death. Whether ischemic neuronal death occurs by apoptosis or necrosis, depends not only on the experimental paradigm "in vitro or in vivo," but also on the experimental subjects "rodents or primates." As the sequential events leading to neuronal death have been characterized mainly by in vitro or rodent studies, very little information is available from in vivo studies focusing primates.
Caspases are central components for the implementation of apoptosis (Nicholson and Thornberry, 1997) . Caspase-3 was demonstrated to be overexpressed in CA1 after transient ischemia, and its specific inhibitor could attenuate ischemic neuronal death (Kuida et al., 1996; Chen et al., 1998; Fink et al., 1998) . Intracerebroventricular infusion of the caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (z-VAD. FMK) reduced infarct volume in focal ischemia (Hara et al., 1997) , and also reduced CA1 neuronal death after global ischemia (Chen et al., 1998) . Virally mediated overexpression of NAIP or XIAP, inhibitors of the apoptotic protein (IAP) family, reduced ischemic damage (Xu et al., 1997 (Xu et al., , 1999 . The caspase-activated DNase (CAD)/ ICAD (an inhibitor of CAD) complex was identified as a substrate of caspase-3 (Liu et al., 1997 (Liu et al., , 1998 (Liu et al., , 1999 Enari et al., 1998; Sakahira et al., 1998) . When the catalytically active caspase-3 cleaves ICAD, the final effector CAD transfers into the nucleus, leading to DNA degradation Sakahira et al., 1998; Mukae et al., 1998) . In spite of many studies demonstrating caspase-3 activation in the postischemic CA1 neurons, only one report has demonstrated translocation of activated CAD in vivo (Tsukada et al., 2001) . It remains obscure whether apoptotic cascade is involved in the ischemic neuronal death of primates.
Recently, mechanisms other than caspase inhibition were suggested to contribute to neuroprotective effects of caspase inhibitors. First, Gray et al. (2001) demonstrated that the tetrapeptide inhibitor tyrosine-valine-alanine-aspartate-chloromethyl ketone (Ac-YVAD-cmk) could rescue cultured neurons from oxygen/glucose deprivation, not by inhibiting apoptotic cascade, but by targeting cathepsin B. Second, Kitao et al. (2001) demonstrated that cultured hippocampal neurons treated with kainate or glutamate showed activation of -calpain and cathepsin B. These findings using in vitro experimental paradigms, are compatible with our "calpain-cathepsin hypothesis," which claimed a role of two cysteine proteases on executing ischemic neuronal death of the monkey hippocampus (Yamashima et al., 1998; Yamashima, 2000) . Accordingly, "calpain-mediated necrosis cascade" and "caspase-3-CAD-mediated apoptosis cascade" should be studied in detail to clarify the mechanism of ischemic neuronal death processing in primates.
MATERIALS AND METHODS

Model of Transient Global Brain Ischemia
The experiments were performed with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by National Institutes of Health (Bethesda, MD). Furthermore, the experimental purposes and procedures were in accordance with the guidelines of Animal Care and Ethics Committee of Kanazawa University.
Japan monkeys (Macaca fuscata, weight 5-8 kg, total number ϭ 45) were used: 6 monkeys for normal controls (n ϭ 2 each for light microscopy, electron microscopy, and molecular analyses, respectively), 15 monkeys for immunofluorescence histochemistry and light microscopy (n ϭ 3 for 3 h, days 1, 2, 3, and 5 after ischemia, respectively), 9 monkeys for electron microscopy (n ϭ 3 for days 1, 3, and 5, respectively), and 15 monkeys for immunoblotting (n ϭ 3 for 3-6 h, days 1, 2, 3, and 5, respectively). The monkeys were anesthetized with 1.5% halothane for induction; they were then orally intubated and maintained with 0.5% halothane in 60% N 2 O and 40% O 2 by a respirator (Acoma KMA anespirator, Tokyo). During the experiment, the monkeys received Ringer's solution; cerebral blood flow (LASERFLO, Vasamedics, USA), blood pressure, and heart rate were monitored. During the experiment, rectal temperature was kept at 37.2-38.3°C, using a thermostat (Gaymar, Orchard Park, NY) or a heating lamp. Blood gases and glucose concentrations were maintained within the normal range.
Transient global ischemia was induced by clamping both the right innominate and the left subclavian arteries for 20 min (Yamashima et al., 1996) with titan bulldog clamps (Bonimed, Germany). After removal of clamps, anesthesia was discontinued and the monkeys were returned to their cages. At 3-6 h, and days 1, 2, 3, and 5 after the ischemic insult, the monkeys were anesthetized again and the brain was quickly removed. Then, the hippocampal CA1 tissues (ϳ5 mm) were resected with microscope, snap-frozen in liquid nitrogen, and stored at Ϫ130°C until extraction of DNA or protein. For immunoblotting of CAD expression, tissues of lymph nodes or intestines were resected and served as positive controls.
For immunofluorescence or ultrastructural analyses, after perfusion of 0.5 L of saline followed by 2 L of 4% paraformaldehyde or glutaraldehyde through the left ventricle, the hippocampal tissues were resected from both the normal and postischemic monkeys. For the immunofluorescence analysis, the hippocampus was further fixed with 4% paraformaldehyde, and was embedded in paraffin.
Light and Electron Microscopy
For light microscopy, 5-m sections of the paraffin-embedded hippocampal tissues after fixation in 4% paraformaldehyde were stained with hematoxylin and eosin (H&E). For electron microscopy, small specimens of CA1 after glutaraldehyde perfusion were further fixed with 2.5% glutaraldehyde for 2 h and subsequently with 1% osmium tetroxide for 1 h at 4°C; the specimens were embedded in the epon-araldite mixture. After staining with toluidine blue for trimming, the ultrathin sections were stained with uranyl acetate and lead citrate for electron microscopic observation (H-600, Hitachi, Tokyo).
DNA Gel Electrophoresis
The 100-mg samples of the CA1 sector were obtained from both the control and postischemic monkeys on days 1 and 3. The tissues were incubated overnight in the lysis buffer (0.5% sodium dodecyl
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sulfate [SDS] , 10 mM Tris-HCl, 0.1 M EDTA) with 0.6 mg of proteinase K at 55°C. DNA was extracted with phenol and phenolchloroform-isoamyl alcohol (25:24:1) and was precipitated overnight in 0.2 M sodium chloride in 100% ethanol at Ϫ80°C. DNA was washed with 75% ethanol and was air dried and dissolved in TE buffer (10 mM Tris-HCl, 1 mM EDTA). Samples were incubated with 50 g/ml RNase for 30 min at 37°C, mixed with the loading buffer, and subjected to electrophoresis on 2% agarose gel.
Antibodies
We used rabbit anti-activated -calpain antibodies made independently by Saido (1:300 -1,000 dilution) (1992) or ImajohOhmi (1:300 dilution) (Kikuchi, Imajoh-Ohmi, 1995) , rabbit anti-LAMP-1 antibody (5 g/ml) (Furuno et al., 1989) , rabbit antiactivated caspase-3 (p20/17) antibody (1:200 dilution) (Urase et al., 1998) , rabbit anti-caspase-3 antibody (1:2,000, 65906E, Pharmingen), goat anti-CAD polyclonal antibody (1:200 -1,000 dilution; CPAN (N-19), Santa Cruz Biotechnology, Inc., CA), and goat anti-DFF-40 (CAD) polyclonal antibody (1:200 -1,000 dilution; CPAN (C-19), Santa Cruz Biotechnology, CA). As the original source of the immunogens for these antibodies was all human, these antibodies cross-reacted well with the monkey antigens.
Immunoblotting
Protein concentrations were determined by Bradford's method. For the immunoblot analysis, the protein (20 g for activated -calpain or caspase-3; 40 g for CAD) being dissolved in RIPA buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1% NP-40, 1% NaDOC, 0.05% SDS), was fractionated on 10% SDS-polyacrylamide gels, and then transferred electrophoretically to polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA) for 2 h at 50 -100 mA, using a transfer system. Membranes were blocked with 5% nonfat dry milk in phosphate-buffered saline (PBS) and 0.1% Tween 20 overnight at 4°C and were then incubated with primary antibody for 2 h at room temperature. They were washed in TBS-T and were incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (Amersham Pharmacia Biotech, NJ). After incubation with 1/2,000 dilution of anti-rabbit or anti-goat IgG conjugated to HRP, the immune complexes were visualized with an enhanced chemiluminescence detection system (ECL, Amersham Pharmacia Biotech).
Immunofluorescence Histochemistry
In this study, 5-m sections of the paraffin-embedded hippocampal tissues were deparaffinized in xylene and were then rehydrated through graded ethanol series (100%, 90%, 80%), washed in PBS, and incubated with 0.3% H 2 O 2 in methanol for 30 min. The sections were blocked with 5% normal goat or rabbit serum in PBS containing 0.5% Triton X-100. The sections were incubated in either of two rabbit anti-activated -calpain antibodies: rabbit anti-LAMP-1 antibody, or goat anti-DFF-40 (CAD) polyclonal antibodies (CPAN [N-19] or CPAN [C-19] , Santa Cruz Biotechnology).
Immunostaining was performed with fluorescein-labeled antirabbit IgG (1:100 or 1:200 dilution; Vector Fluorescent AntiRabbit IgG kit, Vector Laboratories, Burlingame, CA) for 1 h at room temperature. After washing three times in PBS, the sections were covered with mounting medium (Vectashield mounting medium for fluorescence, Vector Laboratories), and the sections were analyzed by LSM510 (Laser Scanning Confocal Microscopy; Carl Zeiss, Tokyo).
RESULTS
Animal Status and Physiological Parameters
Physiological parameters before clamping the arteries were as follows: mean arterial blood pressure, 86.2 Ϯ 12 (mean ϮSD) mm Hg: PaO 2 , 174 Ϯ 29 mm Hg: PaCO 2 , 32.9 Ϯ 2.2 mm Hg: HCO 3 , 30.5 Ϯ 6.8 mm Hg: SaO 2 , 99.5 Ϯ 0.2%: pH, 7.56 Ϯ 0.08: rectal temperature, 37.8 Ϯ 0.4°C: and blood glucose concentrations, 89 Ϯ 20 mg/dl. Immediately after clamping, monkeys showed pupil dilation and the mean arterial blood pressure rose to 169 Ϯ 9.7 mm Hg. However, soon after reperfusion, the monkeys became normotensive, and all the physiological parameters became normal. Cerebral blood flow was ϳ40 ml/100 g brain/min before ischemia and 0 -1 ml/100 g brain/min during the ischemic insult. After ischemia, the monkeys showed uneventful recovery within 1-3 h.
Light and Electron Microscopy
H&E staining showed that the nonischemic (control) CA1 neurons had round and vesicular nucleus (Fig. 1C) . In contrast, on day 1 after ischemia ( Fig. 1, d1 ), approximately two-thirds of CA1 neurons displayed mild shrinkage and pyknotic degeneration. On day 2 after ischemia ( Fig. 1, d2) , almost all CA1 neurons showed shrinkage of the cell body and pyknosis of the nucleus. On days 3-5 (Fig. 1, d3, d5 ), all CA1 neurons exhibited eosinophilic coagulation necrosis characterized by reddish cytoplasm and diffusely condensed nucleus. Although abundant cell debris remained in the CA1 sector with glial proliferation, delayed neuronal death was actually completed on day 5 (Fig. 1, d5) .
Consistent with these light microscopic features, ultrastructural findings of the postischemic CA1 neurons on days 1-5 (Fig. 2, d1 , d3, d5) displayed diffuse or punctuate chromatin condensation, compared with the control (Fig. 2C ), but they never showed the coarse chromatin condensation known as apoptotic bodies. The cytoplasm exhibited marked degeneration, such as vacuolation of the rough endoplasmic reticulum and Golgi apparatus, and swelling of mitochondria (Fig. 2, d1, d3) . The postischemic CA1 neuron on day 5 (Fig. 2, d5) showed frank membrane disruption, lysis of cell organelles, and punctate chromatin condensation.
DNA Gel Electrophoresis
Neither DNA laddering nor smear patterns were observed in CA1 of the nonischemic control (Fig. 3C) . The DNA smear pat-tern was detected very slightly in the postischemic CA1 on day1 (Fig. 3, d1 ) and became intense on day 3 after ischemia ( Fig. 3, d3) . However, DNA laddering was not detected on days 1 and 3.
Immunoblotting and Immunofluorescence Histochemistry of Activated -Calpain
Time-dependent changes in the expression of activated -calpain were analyzed using two distinct antibodies that can specifically recognize the 76-kDa activated form. The positive reaction using these antibodies indicates the presence of -calpain activation.
On immunoblotting, the internal control protein ␣-tubulin (Fig. 4, lower lane) showed a gradual decrease, associated with the development of neuronal degeneration until day 5. In contrast, immediately after ischemia (Fig. 4, 3 h ) until day 5 (Fig. 4, d5) , either Imajoh-Ohmi (Fig. 4, upper lane) or Saido (Fig. 4 , middle lane) antibodies showed overexpression of activated -calpain compared with the control (C). This indicates that -calpain activation in the monkey CA1 neurons was sustained as long as 5 days, maximal on day 3 after 20 min ischemia.
Immunofluorescence histochemistry using two antibodies essentially showed the same result (Fig. 5) . Using Saido antibody (S), FITC (green) labeling activated -calpain was seen primarily in the neuropil but was weak in the perikarya of the control CA1 neurons, as shown in Figure 5C (S). In contrast, immediately after ischemia until day 2, d2(S), the postischemic CA1 neurons showed granular immunoreactivity in the perikarya. Immunoreactivity became maximal on day 2, d2(S), as coarse granules. This translocation was confirmed on all six postischemic monkeys on days 2 and 3. On day 3, d3(S), concomitant with attenuation of granular immunoreactivity, the immunoreactivity of the perikarya became intense. Using Imajoh-Ohmi antibody (O), the same staining pattern was observed in the postischemic day 2, d2(O), neurons compared with the control, as shown in Figure 5C (O).
Immunoblotting and Immunofluorescence Histochemistry of LAMP-1
On immunoblotting, a single band indicating brain LAMP-1 was seen consistently at ϳ60 kDa in both the control and post- 
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YAMASHIMA ET AL. ischemic CA1 (data not shown). FITC (green) labeling LAMP-1 (Fig. 6 ) displayed a dynamic translocation like activated -calpain. The LAMP-1 immunoreactivity was seen as fine granules in the perikarya of the control CA1 neurons (Fig. 6C) . In contrast, from immediately after ischemia (Fig. 6, 3 h ) until day 1 (Fig. 6, d1) , the immunoreactivity of lysosomes increased, showing a coarse granular pattern. On day 2 after ischemia ( Fig. 6, d2) , almost all CA1 neurons showed remarkable LAMP-1 immunoreactivity by aggregation of such granules. On day 3 after ischemia ( Fig. 6, d3) , the LAMP-1 immunoreactivity became intense throughout the perikarya, showing a marked contrast to the control (Fig. 6C) . These findings were confirmed in all nine postischemic monkeys on days 1, 2, and 3. Because LAMP-1 should be localized at lyso- Immunofluorescent confocal images of the lysosomeassociated membrane protein (LAMP)-1 in the representative CA1 neurons of the control (C), immediately after ischemia (3 h), days 1 (d1), 2 (d2), 3 (d3), and 5 (d5). LAMP-1 immunostaining shows a similar translocation with activated -calpain: the immunoreactivity of the perikarya is upregulated from immediately after ischemia (3 h) until day 5 (d5). Coarse granular staining becomes intense on day 2 (d2), while the perikarya are diffusely stained on day 3 (d3). On day 5 (d5), the immunoreactivity decreases associated with neuronal degeneration. Scale bar ‫؍‬ 5 m
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somes as fine granules, such translocation indicates rupture of the lysosomal membrane. On day 5 (Fig. 6, d5 ), the number of immunoreactive CA1 neurons and their immunointensity decreased with development of neuronal degeneration. Instead, the satellite glial cells showed remarkable LAMP-1 immunoreactivity on days 3-5 (data not shown).
Expression of Caspase-3 and CAD
Rabbit anti-caspase-3 antibody recognizes both the 32-kDa unprocessed pro-caspase-3 and the 17-kDa subunit of the activated caspase-3. On immunoblotting, the protein expression of procaspase-3 (32 kDa) increased on days 1-5 (Fig. 7, upper lane, d1 , d3, d5) despite the breakdown of the internal control protein ␣-tubulin (Fig. 7, lower lane) . In contrast, immunoblotting could demonstrate essentially no increase in the activated caspase-3 (17 kDa) at any time points in the postischemic CA1 (Fig. 7, middle lane) . In both the normal and postischemic CA1 neurons, anti-p20/17 antibody detected little immunostaining for the activated caspase-3 (data not shown).
Goat anti-CAD polyclonal antibody (N-19) recognizes the Nterminus of CAD, while goat anti-CAD polyclonal antibody (C-19) recognizes the C-terminus of CAD. On immunoblotting using two distinct antibodies, CAD expression was upregulated on days 1 and/or 2 (Fig. 8, d1 , d2, upper and third lanes), but the expression was much less, compared with lymph node or intestine tissues (Fig. 8, Lymph. and Intest.).
DISCUSSION
In the present experimental paradigm using nonhuman primates, light microscopy demonstrated eosinophilic coagulation necrosis, while electron microscopy showed frank membrane disruption and punctate chromatin condensation. Furthermore, DNA gel electrophoresis did not show a ladder pattern, but rather a smear pattern. Accordingly, it is reasonable to conclude that in the postischemic CA1 neuronal death of monkeys, the final pattern of cell death was not apoptosis, but necrosis. However, it is likely that CAD might have partially participated in DNA degradation of the postischemic CA1 neurons in monkeys (Tsukada et al., 2001) . Brunk et al. (1997) suggested a quantitative relationship between the amount of lysosomal rupture and the mode of cell death: low-intensity stresses trigger a limited release of lysosomal Immunoblot analysis of CAD using goat anti-CAD polyclonal antibody N-19 (upper lane, N-) and goat anti-CAD polyclonal antibody C-19 (third lane, C-) in the control (C), 6 h, and days 1 (d1), 2 (d2), and 3 (d3) after ischemia. CAD expression increased transiently on days 1 and/or 2 (d1, d2), but was much less in the CA1 sector compared with lymph node or intestine tissues (Lymph. and Intest.). enzymes to the cytoplasm followed by apoptosis, whereas highintensity stresses lead to a generalized lysosomal rupture followed by necrosis. In seeking such possibility, we have carefully studied monkeys undergoing 10-min ischemic insult, using the same experimental paradigm. However, the CA1 neuronal death pattern was also necrotic as represented by eosinophilic coagulation necrosis, with the total number of necrotic neurons becoming approximately one-half compared with that of the 20-min ischemic insult (data not shown here). What determines the cell death fate of the monkey CA1 neurons other than the intensity of ischemic insults?
Photo-oxidative disruption of lysosomal membranes produced apoptosis in the cultured human fibroblasts (Brunk et al., 1997) , while translocation of lysosomal proteases caused apoptosis also in the lysosome-rich, macrophage-like cells (Li et al., 2000) . These might occur directly by pro-caspase activation and/or indirectly by mitochondrial attack with ensuing discharge of pro-apoptotic factors. In contrast, extralysosomal leakage of cathepsins B and L after -calpain activation (Yamashima et al., 1998) caused necrosis in the monkey experimental paradigm, and the specific cathepsin inhibitors such as CA-074 or E-64c could inhibit neuronal death even by the postischemic injection (Yamashima et al., 1998; Tsuchiya et al., 1999; Yoshida et al., 2002) . The present study demonstrates that the postischemic CA1 neuronal death in monkeys occurred not by apoptosis but by necrosis. The necrotic cell death pathway by calpain-mediated lysosomal rupture appears to be crucial for executing the postischemic CA1 neuronal death processing in primates.
In the gerbil hippocampus, Saido et al. (1993) reported that transient global forebrain ischemia induced two distinct phases of ␣-spectrin proteolysis on day 1: an acute phase within 15 min, and a late, drastic and persistent phase after 4 -24 h. Furthermore, in the rat retina with ischemia-reperfusion injury, Sakamoto et al. (2000) also reported that activation of -calpain, occurring immediately after ischemia until day 1, was associated with neuronal death. In contrast, in the present experimental paradigm, calpain activation was sustained as long as 5 days: from immediately after ischemia until day 5, maximal on day 3. Long-standing calpain activation with dynamic translocation in the monkey CA1 neurons showed a remarkable contrast to only one day calpain activation in the lower-species animals. As CAD upregulation was mild and occurred transiently on days 1-2 in monkeys, calpain activation lasting as long as 5 days appears to be a rather critical factor for the CA1 neuronal death, completed on days 3-5. Although the precise mechanisms of sustained calpain activation and lysosomal membrane disruption await further elucidation, the present immunofluorescence histochemical data on day 2 showed lysosomal localization of activated -calpain. Unfortunately, the present study could not demonstrate co-localization of activated -calpain and LAM-1, because each antibody was raised in the same animal species, rabbits. Previously using the same antibody, however, we demonstrated that the immunoreactivity of activated -calpain was ultrastructurally localized at the vacuolated or disrupted membrane of lysosomes in the postischemic CA1 neurons (Yamashima et al., 1996; Yamashima, 2000) . Taken together, it is likely that lysosomal localization of activated -calpain induced its disruption after the ischemic insult presumably with the aid of oxidative stress (Roberg and Ollinger, 1998) .
The lysosomal membrane is a physical barrier that prevents hydrolytic enzymes from digesting the cell's own cytoplasm, but its severe damage can cause cell necrosis in the pathologic states. De Duve and Wattiaux (1966) first reported that the lethal cell injury occurs by the release of hydrolytic enzymes from damaged lysosomes. Spreading of hydrolytic enzymes into the cytoplasm by the lysosomal membrane injury or rupture, was confirmed in both heart (Brachfeld, 1969; Ichihara et al., 1987; Molchanova et al., 1991 ) and brain (White et al., 1992; Chan, 1996) ischemic injuries. The translocation of cathepsin B from lysosomes to cytosol and nucleus was confirmed also in the bile salt-induced and tumor necrosis factor (TNF)-triggered hepatic apoptosis Guicciardi et al., 2001) . Similarly, early cathepsin D translocation from secondary lysosomes to the cytosol was confirmed in the oxidative stress-induced apoptosis (Roberg and Ollinger 1998) . Furthermore, Foghsgaard et al. (2001) recently found that cathepsin B, which disappeared from perinuclear granules (colocalizing with lysosomal markers) and distributed diffusely throughout the cell, is capable of acting as a dominant execution protease in tumor cell apoptosis induced by TNF. Using the monkey experimental paradigm, translocations of cathepsins B and L (Yamashima et al., 1998; Yamashima, 2000) as well as DNase II (Tsukada et al., 2001) , were already suggested by immunohistochemistry in the postischemic CA1 neurons. Furthermore, the translocation of LAMP-1 indicating loss of lysosomal integrity was confirmed in this study. These data suggest that sustained calpain activation in the postischemic CA1 neurons may cause long-standing lysosomal membrane disruption with the resultant consecutive leakage of lysosomal enzymes, including cathepsins B, L, and DNase II from immediately after ischemia until day 5.
In the present model, both morphologic (membrane disruption without apoptotic bodies) and DNA (smear pattern) analyses demonstrated that the final cell death pattern is not apoptotic but necrotic. Our previous experiments showed that the postischemic CA1 neurons were protected from delayed neuronal death by the specific cathepsin B inhibitor CA-074 (ϳ67%) or the calpain, and cathepsins B, L inhibitor E-64c (ϳ84%) (Tsuchiya et al., 1999) . In a recent study (Yoshida et al., 2002) , we showed that not only CA1 neurons but also cortical, caudate-putaminal, and Purkinje neurons after the same ischemic insult were saved from delayed neuronal death using these inhibitors. Accordingly, it is probable that cathepsins B and L (Yamashima et al., 1998; Tsuchiya et al., 1999) contributed to the breakdown of cell constitutive proteins while CAD, DNase II, and cathepsins (Tsukada et al., 2001) participated in the random degradation of DNA.
As it is probable that the specific calpain and/or cathepsin inhibitors might have just delayed the process of cell destruction after ischemia, we have extensively examined post-treatment monkeys on day 30 after the 20-min ischemic insult. We were able to confirm consistently the same protective effect of CA-074 and E-64c (data not shown here) as demonstrated on day 5. Considering that the duration of ischemia in our experimental paradigm was as long as 20 min, we might have observed relatively severe form of ischemic neuronal damage in CA1 neurons as shown in Figures 1 and   798 YAMASHIMA ET AL.
Even if it
were not justifiable to generalize the results obtained in the present study to all previous rodent models of relatively mild ischemia, our "calpain-cathepsin hypothesis" (Yamashima et al., 1998; Yamashima, 2000) would contribute to the understanding of the mechanisms underlying ischemic neuronal death in primates. The basic concept of "calpain-cathepsin hypothesis" was recently confirmed in C. elegans . Gray et al. (2001) reported that the tetrapeptide caspase inhibitor Ac-YVAD-cmk could protect cultured neurons from oxygen/glucose deprivation, not by inhibiting apoptotic cascade but by targeting cathepsin B. Because of the possible cross-talks between apoptotic and necrotic cascades, dichotomy of apoptosis-necrosis might not have so much significance on discussing the death or survival mechanisms of nondividing cells, such as neurons. Most importantly, the landscape of ischemic brain injury mechanisms and strategy for neuroprotection should steadily change, if one focuses on sustained calpain activation and the resultant leakage of lysosomal enzymes .
